Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of KN510, KN713

Clinical trial NCT06012708 · COMPLETED

Trial details

NCT number: NCT06012708
Sponsor: New Cancer Cure-Bio Co.,Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2023-09-11
Primary completion: 2024-11-05
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.